Advertisement
News
Advertisement

Sickle cell-focused biotech AesRx lands $1.38M

Mon, 05/23/2011 - 6:35am
Mass High Tech: The Journal of New England Technology

AesRx LLC, a biotech firm in Newton, has secured about $1.38 million in a debt and securities financing, according to a regulatory filing.

The company indicated in the filing that it plans to bring in about $3.5 million total from the financing.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading